Exact Mass: 325.1808

Exact Mass Matches: 325.1808

Found 123 metabolites which its exact mass value is equals to given mass value 325.1808, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cycloxydim

2-[(1E)-N-Ethoxybutanimidoyl]-3-hydroxy-5-(tetrahydro-2H-thiopyra n-3-yl)-2-cyclohexen-1-one

C17H27NO3S (325.1712)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3045

   

Ergonovine

(4R,7R)-N-[(2S)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide

C19H23N3O2 (325.179)


Ergonovine is only found in individuals that have used or taken this drug. It is an ergot alkaloid with uterine and vascular smooth muscle contractile properties. [PubChem]Ergonovine directly stimulates the uterine muscle to increase force and frequency of contractions. With usual doses, these contractions precede periods of relaxation; with larger doses, basal uterine tone is elevated and these relaxation periods will be decreased. Contraction of the uterine wall around bleeding vessels at the placental site produces hemostasis. Ergonovine also induces cervical contractions. The sensitivity of the uterus to the oxytocic effect is much greater toward the end of pregnancy. The oxytocic actions of ergonovine are greater than its vascular effects. Ergonovine, like other ergot alkaloids, produces arterial vasoconstriction by stimulation of alpha-adrenergic and serotonin receptors and inhibition of endothelial-derived relaxation factor release. It is a less potent vasoconstrictor than ergotamine. As a diagnostic aid (coronary vasospasm), ergonovine causes vasoconstriction of coronary arteries. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

MEGA

N-(2,6-dimethylphenyl)-4-[[2-(ethylamino)acetyl]amino]benzamide

C19H23N3O2 (325.179)


   

Benzydamine N-oxide

3-[(1-benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropanamine oxide

C19H23N3O2 (325.179)


   

Ergobasin

N-(1-Hydroxypropan-2-yl)-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidate

C19H23N3O2 (325.179)


   

(3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))-5-Methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)octan-6-ol carbamate

(3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))-5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)octan-6-ol carbamic acid

C17H27NO5 (325.1889)


   
   

Awajanomycin

Awajanomycin

C17H27NO5 (325.1889)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   
   
   
   

4-ethyl-11,15-dihydroxy-12-methoxy-5-methyl-13-oxa-4-aza-tricyclo[10.2.1.02,5]-pentadec-1-en-3-one|phyllostictine A

4-ethyl-11,15-dihydroxy-12-methoxy-5-methyl-13-oxa-4-aza-tricyclo[10.2.1.02,5]-pentadec-1-en-3-one|phyllostictine A

C17H27NO5 (325.1889)


   
   
   
   
   
   
   

Necrosis Inhibitor, IM-54

Necrosis Inhibitor, IM-54

C19H23N3O2 (325.179)


   
   
   
   
   
   
   

Ergonovine

Ergometrine

C19H23N3O2 (325.179)


A monocarboxylic acid amide that is lysergamide in which one of the hydrogens attached to the amide nitrogen is substituted by a 1-hydroxypropan-2-yl group (S-configuration). An ergot alkaloid that has a particularly powerful action on the uterus, its maleate (and formerly tartrate) salt is used in the active management of the third stage of labour, and to prevent or treat postpartum of postabortal haemorrhage caused by uterine atony: by maintaining uterine contraction and tone, blood vessels in the uterine wall are compressed and blood flow reduced. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D012102 - Reproductive Control Agents > D010120 - Oxytocics CONFIDENCE Claviceps purpurea sclerotia relative retention time with respect to 9-anthracene Carboxylic Acid is 0.382 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.380 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.373 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.375

   

Dyclonine hydrochloride

Dyclonine hydrochloride

C18H28ClNO2 (325.1808)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent Dyclonine (Dyclocaine) hydrochloride is an orally effective ALDH covalent inhibitor (crosses blood-brain barrier), with an IC50 of 35 μM for ALDH2 and 76 μM for ALDH3A1. Dyclonine hydrochloride has sensitizing activities for targeted cancer cells and antibacterial. Dyclonine hydrochloride is also a local anesthetic that blocks the transmission of various nerve impulses or stimuli and inhibits the sensation of touch and pain[1][2][3].

   

C19H23N3O2_(3S,6S)-3-Methyl-6-{[2-(2-methyl-3-buten-2-yl)-1H-indol-3-yl]methyl}-2,5-piperazinedione

NCGC00386110-01_C19H23N3O2_(3S,6S)-3-Methyl-6-{[2-(2-methyl-3-buten-2-yl)-1H-indol-3-yl]methyl}-2,5-piperazinedione

C19H23N3O2 (325.179)


   

Ergonovine maleate

Ergonovine maleate

C19H23N3O2 (325.179)


   

Ergometrinine

Ergometrinine

C19H23N3O2 (325.179)


CONFIDENCE Claviceps purpurea sclerotia

   

ERGONOVINE MALEATE_major

ERGONOVINE MALEATE_major

C19H23N3O2 (325.179)


   
   
   
   
   
   
   
   

IM-54

1-methyl-3-(1-methyl-1H-indol-3-yl)-4-(pentylamino)-1H-pyrrole-2,5-dione

C19H23N3O2 (325.179)


   

6H-Purin-6-one, 2-amino-9-[(2R)-4,4-diethoxy-2-(hydroxymethyl)butyl]-1,9-dihydro-

6H-Purin-6-one, 2-amino-9-[(2R)-4,4-diethoxy-2-(hydroxymethyl)butyl]-1,9-dihydro-

C14H23N5O4 (325.175)


   

1,4,7,10-Tetraoxa-13-azacyclopentadecane, 13-(2-methoxyphenyl)

1,4,7,10-Tetraoxa-13-azacyclopentadecane, 13-(2-methoxyphenyl)

C17H27NO5 (325.1889)


   

Boc-3-Hydroxy-1-adamantyl-D-glycine

Boc-3-Hydroxy-1-adamantyl-D-glycine

C17H27NO5 (325.1889)


   
   

(S)-1-((1,3,2-DIOXABOROLAN-2-YL)OXY)-3-METHYL-1,1-DIPHENYLBUTAN-2-AMINE

(S)-1-((1,3,2-DIOXABOROLAN-2-YL)OXY)-3-METHYL-1,1-DIPHENYLBUTAN-2-AMINE

C19H24BNO3 (325.1849)


   
   

2-[2-hydroxy-6-methyl-2-(4-methylphenyl)-3H-imidazo[1,2-a]pyridin-3-yl]-N,N-dimethylacetamide

2-[2-hydroxy-6-methyl-2-(4-methylphenyl)-3H-imidazo[1,2-a]pyridin-3-yl]-N,N-dimethylacetamide

C19H23N3O2 (325.179)


   

(2S)-2-{Diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine

(2S)-2-{Diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine

C20H27NOSi (325.1862)


   

tert-Butyl 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)piperazine-1-carboxylate

tert-Butyl 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)piperazine-1-carboxylate

C14H23N5O4 (325.175)


   

4-Cyano-4-pentyl-p-terphenyl

4-Cyano-4-pentyl-p-terphenyl

C24H23N (325.183)


   

(R)-N-Boc-3-hydroxyadaMantylglycine

(R)-N-Boc-3-hydroxyadaMantylglycine

C17H27NO5 (325.1889)


   
   

bis(pentamethylcyclopentadienyl)manganese

bis(pentamethylcyclopentadienyl)manganese

C20H30Mn (325.1728)


   

(R)-diphenylprolinol trimethyl silyl ether

(R)-diphenylprolinol trimethyl silyl ether

C20H27NOSi (325.1862)


   

tricyclopentylphosphine tetrafluorobora&

tricyclopentylphosphine tetrafluorobora&

C15H27BF4P (325.1879)


   
   

1-(8-Methyl-2,5,11,14-tetraoxa-8-azabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-yl)ethanol

1-(8-Methyl-2,5,11,14-tetraoxa-8-azabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-yl)ethanol

C17H27NO5 (325.1889)


   

N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]cyclohexanecarboxamide

N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]cyclohexanecarboxamide

C19H23N3O2 (325.179)


   

N,N,3,5-Tetramethyl-4-(phenanthren-9-YL)aniline

N,N,3,5-Tetramethyl-4-(phenanthren-9-YL)aniline

C24H23N (325.183)


   

N-(2,6-dimethylphenyl)-4-[[2-(ethylamino)acetyl]amino]benzamide

N-(2,6-dimethylphenyl)-4-[[2-(ethylamino)acetyl]amino]benzamide

C19H23N3O2 (325.179)


   

1-methyl-3-(1-methyl-1H-indol-3-yl)-4-(pentylamino)-1H-pyrrole-2,5-dione

1-methyl-3-(1-methyl-1H-indol-3-yl)-4-(pentylamino)-1H-pyrrole-2,5-dione

C19H23N3O2 (325.179)


   

(3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))-5-Methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)octan-6-ol carbamate

(3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))-5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)octan-6-ol carbamic acid

C17H27NO5 (325.1889)


   

5-[(3-Aminopropyl)-amino]-5-deoxyadenosine

5-[(3-Aminopropyl)-amino]-5-deoxyadenosine

C13H23N7O3+2 (325.1862)


   

9-[6(RS)-8-diamino-5,6,7,8-tetradeoxy-beta-D-ribo-octofuranosyl]-9H-purin-6-amine

9-[6(RS)-8-diamino-5,6,7,8-tetradeoxy-beta-D-ribo-octofuranosyl]-9H-purin-6-amine

C13H23N7O3+2 (325.1862)


   

1-(4-methoxyphenyl)-N,N-dipropyl-4-pyrazolo[3,4-d]pyrimidinamine

1-(4-methoxyphenyl)-N,N-dipropyl-4-pyrazolo[3,4-d]pyrimidinamine

C18H23N5O (325.1903)


   

1-[2-[3-(Dimethylamino)phenyl]-4-pyrimidinyl]-4-piperidinecarboxamide

1-[2-[3-(Dimethylamino)phenyl]-4-pyrimidinyl]-4-piperidinecarboxamide

C18H23N5O (325.1903)


   

1-[4-[3-(Dimethylamino)phenyl]-2-pyrimidinyl]-4-piperidinecarboxamide

1-[4-[3-(Dimethylamino)phenyl]-2-pyrimidinyl]-4-piperidinecarboxamide

C18H23N5O (325.1903)


   

1-[5-[3-(Dimethylamino)phenyl]-2-pyrimidinyl]-4-piperidinecarboxamide

1-[5-[3-(Dimethylamino)phenyl]-2-pyrimidinyl]-4-piperidinecarboxamide

C18H23N5O (325.1903)


   
   

4-Phenoxy-1-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone

4-Phenoxy-1-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone

C19H23N3O2 (325.179)


   

N-[(1,5-dimethyl-2-pyrrolyl)methyl]-1-(4-methylphenyl)-5-oxo-3-pyrrolidinecarboxamide

N-[(1,5-dimethyl-2-pyrrolyl)methyl]-1-(4-methylphenyl)-5-oxo-3-pyrrolidinecarboxamide

C19H23N3O2 (325.179)


   
   
   
   
   

3-[5-cyano-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-1-yl]-N,N-dimethylpropan-1-aminium

3-[5-cyano-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-1-yl]-N,N-dimethylpropan-1-aminium

C20H22FN2O+ (325.1716)


   

1-[3-(4-Butoxyphenyl)-3-oxopropyl]piperidinium chloride

1-[3-(4-Butoxyphenyl)-3-oxopropyl]piperidinium chloride

C18H28ClNO2 (325.1808)


   

N-ethyl-N-[[(2R,3S,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

N-ethyl-N-[[(2R,3S,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

C19H23N3O2 (325.179)


   

N-ethyl-N-[[(2S,3S,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

N-ethyl-N-[[(2S,3S,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

C19H23N3O2 (325.179)


   

N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

C19H23N3O2 (325.179)


   

N-ethyl-N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

N-ethyl-N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

C19H23N3O2 (325.179)


   

N-ethyl-N-[[(2S,3R,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

N-ethyl-N-[[(2S,3R,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

C19H23N3O2 (325.179)


   

N-ethyl-N-[[(2R,3R,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

N-ethyl-N-[[(2R,3R,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-pyridinecarboxamide

C19H23N3O2 (325.179)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(R)-citalopram(1+)

(R)-citalopram(1+)

C20H22FN2O+ (325.1716)


   

N-(1-hydroxypropan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

N-(1-hydroxypropan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C19H23N3O2 (325.179)


D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C19H23N3O2 (325.179)


   

(3s,6r)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

(3s,6r)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C19H23N3O2 (325.179)


   

(4r,7r)-n-[(2r)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

(4r,7r)-n-[(2r)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C19H23N3O2 (325.179)


   

6-hydroxy-8-methyl-7-[(2-methylpropanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

6-hydroxy-8-methyl-7-[(2-methylpropanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C17H27NO5 (325.1889)


   

4-ethyl-11,15-dihydroxy-12-methoxy-5-methyl-13-oxa-4-azatricyclo[10.2.1.0²,⁵]pentadec-1-en-3-one

4-ethyl-11,15-dihydroxy-12-methoxy-5-methyl-13-oxa-4-azatricyclo[10.2.1.0²,⁵]pentadec-1-en-3-one

C17H27NO5 (325.1889)


   

(4s,7r)-n-[(2s)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

(4s,7r)-n-[(2s)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C19H23N3O2 (325.179)


   

1,2-dihydroxy-8-(3-hydroxydec-1-en-1-yl)-4-methyl-6-oxa-3-azabicyclo[3.2.1]oct-2-en-7-one

1,2-dihydroxy-8-(3-hydroxydec-1-en-1-yl)-4-methyl-6-oxa-3-azabicyclo[3.2.1]oct-2-en-7-one

C17H27NO5 (325.1889)


   

(2e)-3-(3-heptyloxiran-2-yl)-1-[(3r,4s,5s)-2,3,4-trihydroxy-5-methyl-4,5-dihydropyrrol-3-yl]prop-2-en-1-one

(2e)-3-(3-heptyloxiran-2-yl)-1-[(3r,4s,5s)-2,3,4-trihydroxy-5-methyl-4,5-dihydropyrrol-3-yl]prop-2-en-1-one

C17H27NO5 (325.1889)


   

3-(3-heptyloxiran-2-yl)-1-(2,3,4-trihydroxy-5-methyl-4,5-dihydropyrrol-3-yl)prop-2-en-1-one

3-(3-heptyloxiran-2-yl)-1-(2,3,4-trihydroxy-5-methyl-4,5-dihydropyrrol-3-yl)prop-2-en-1-one

C17H27NO5 (325.1889)


   

(1e,5r,11s,12s,15s)-4-ethyl-11,15-dihydroxy-12-methoxy-5-methyl-13-oxa-4-azatricyclo[10.2.1.0²,⁵]pentadec-1-en-3-one

(1e,5r,11s,12s,15s)-4-ethyl-11,15-dihydroxy-12-methoxy-5-methyl-13-oxa-4-azatricyclo[10.2.1.0²,⁵]pentadec-1-en-3-one

C17H27NO5 (325.1889)


   

(3s,6s)-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C19H23N3O2 (325.179)


   

(4r,7r)-n-[(2s)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

(4r,7r)-n-[(2s)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C19H23N3O2 (325.179)


   

(4s,7r)-n-(1-hydroxypropan-2-yl)-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

(4s,7r)-n-(1-hydroxypropan-2-yl)-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C19H23N3O2 (325.179)


   

(2s,3r,4s)-2-heptyl-3,4-dihydroxy-6-methoxy-3-methyl-7-methylidene-2h,4h-pyrano[2,3-c]pyrrol-5-one

(2s,3r,4s)-2-heptyl-3,4-dihydroxy-6-methoxy-3-methyl-7-methylidene-2h,4h-pyrano[2,3-c]pyrrol-5-one

C17H27NO5 (325.1889)


   

(2e)-3-[(2r,3r)-3-heptyloxiran-2-yl]-1-[(3r,4s,5s)-2,3,4-trihydroxy-5-methyl-4,5-dihydropyrrol-3-yl]prop-2-en-1-one

(2e)-3-[(2r,3r)-3-heptyloxiran-2-yl]-1-[(3r,4s,5s)-2,3,4-trihydroxy-5-methyl-4,5-dihydropyrrol-3-yl]prop-2-en-1-one

C17H27NO5 (325.1889)


   

n-(1-hydroxypropan-2-yl)-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

n-(1-hydroxypropan-2-yl)-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C19H23N3O2 (325.179)


   

(1s,4r,5s,8r)-1,2-dihydroxy-8-[(1e,3r)-3-hydroxydec-1-en-1-yl]-4-methyl-6-oxa-3-azabicyclo[3.2.1]oct-2-en-7-one

(1s,4r,5s,8r)-1,2-dihydroxy-8-[(1e,3r)-3-hydroxydec-1-en-1-yl]-4-methyl-6-oxa-3-azabicyclo[3.2.1]oct-2-en-7-one

C17H27NO5 (325.1889)


   

(1r,4s,5r,8s)-1,2-dihydroxy-8-[(1e,3s)-3-hydroxydec-1-en-1-yl]-4-methyl-6-oxa-3-azabicyclo[3.2.1]oct-2-en-7-one

(1r,4s,5r,8s)-1,2-dihydroxy-8-[(1e,3s)-3-hydroxydec-1-en-1-yl]-4-methyl-6-oxa-3-azabicyclo[3.2.1]oct-2-en-7-one

C17H27NO5 (325.1889)


   

(3s,6s)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C19H23N3O2 (325.179)


   

2-heptyl-3,4-dihydroxy-6-methoxy-3-methyl-7-methylidene-2h,4h-pyrano[2,3-c]pyrrol-5-one

2-heptyl-3,4-dihydroxy-6-methoxy-3-methyl-7-methylidene-2h,4h-pyrano[2,3-c]pyrrol-5-one

C17H27NO5 (325.1889)


   

(4s,7r)-n-[(2r)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

(4s,7r)-n-[(2r)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C19H23N3O2 (325.179)


   

(3s)-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

(3s)-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C19H23N3O2 (325.179)


   

3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C19H23N3O2 (325.179)


   

(3s,6s)-3-methyl-6-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-methyl-6-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C19H23N3O2 (325.179)


   

(3e)-6-{[(2r,3r,4e)-1,3-dihydroxy-2,4-dimethylhept-4-en-1-ylidene]amino}-2,4-dimethyl-5-oxohex-3-enoic acid

(3e)-6-{[(2r,3r,4e)-1,3-dihydroxy-2,4-dimethylhept-4-en-1-ylidene]amino}-2,4-dimethyl-5-oxohex-3-enoic acid

C17H27NO5 (325.1889)